Wednesday , May 18 2022

The intestine also creates its own blood cells



The intestine has a stem containing mammalian cells that make up 10% of blood circulation, according to investigations from Columbia University (United States) scientists.

Up to now, blood cells have been created by the cells of the bone marrow from the hematopoietic cells. However, when Megan Sykes was surprised by the intestinal reservoirs led by the Director of Immunology Translational in Colombia, the blood of the patients receiving the transplant had cellular donors. .

Researchers continued to use donor blood cells in the fountain, with kidneys given to hematopoietic cells. According to the researchers, a patient's blood circulation in circulation had no effect on their transplants. "Patients with high levels of dopamine do not need immunosuppression in the past, and the reduction of immunosuppression could be better," says Sykes.

The production of transplanted organs from hematopoietic stem cells increases interference between proliferation and receptor and increases transplant tolerance. "This can improve the lives of transplanted patients, and our ultimate goal is to achieve immune tolerance, to eliminate immunosuppression completely and to enable the patient to treat insulin, that is, the" Holy Grail "," the researcher.

According to scientists, cell transplants after intestinal transplants suggest that circulating cells in the intestinal tract suggest that they receive and receive liver tissue in the receptor tissue. Likewise, white blood cell counters that are received after the transplant will be able to tolerate donor tissue.

"We are clearly demonstrating that interference between the two cells that protect the immune system of the patients is to protect patients from transplants," says Sykes. In fact, while patients with more blood donors have lower organ cancellation rates, the results indicate new strategies for organ transplant management.

Nowadays, researchers are planning a study that will help increase the hematopoietic inflammatory cells during intestinal transplantation. This will reduce the blood circulation levels of the major provider, the immune tolerance and the need for immunosuppressive drugs.

Source link